Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 8;7(2):e001673. doi: 10.1136/rmdopen-2021-001673

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

Multiple logistic regression analyses of baseline predictors of LDA, based on (A) DAS28-4(ESR) ≤3.2 and (B) CDAI ≤10, or remission, based on (C) ACR-EULAR Boolean remission criteria, (D) DAS28-4(ESR) <2.6 and (E) CDAI ≤2.8, with tofacitinib modified-release 11 mg once daily plus methotrexate at week 24 of the open-label phase. *Australia, Philippines, South Korea and South Africa. ACR, American College of Rheumatology; CCP, cyclic citrullinated peptide; CDAI, Clinical Disease Activity Index; DAS28-4(ESR), Disease Activity Score in 28 joints, erythrocyte sedimentation rate; EULAR, European Alliance of Associations for Rheumatology; HAQ-DI, Health Assessment Questionnaire-Disability Index; LDA, low disease activity; RoW, Rest of the World.